The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) at Rutgers University received a $5 million National Institutes of Health grant to launch outreach campaigns and expand access to COVID-19 testing for underserved and vulnerable communities throughout the state. The Rutgers-led study called the New Jersey Healthcare Essential Worker Outreach and Education Study – Testing Overlooked Occupations, or NJ HEROES TOO, will be funded under NIH’s Rapid Acceleration of Diagnostics (RADx) initiative, RADx Underserved Populations (RADx-UP) program, according to the university. To read the full story.
Home / Community / Rutgers awarded $5M to improve access to COVID testing in underserved communities
Recent Posts
- Drug Metabolism Group Spring Symposium and Vendor Exhibition on May 5th
- Rutgers Health Begins Clinical Trial to Determine If B1 Can Slow Alzheimer’s Disease.
- Join NJACTS on 4/29 for a Multilingual Research Methods Workshop – Register by 4/22!
- NJIT’s Center for Translational Research Quickens Technology’s Pace to Market.
- Join Us for Clinical Trials Day on May 20th!
Categories
- Community (2,475)
- Covid (999)
- CTO Events (6)
- News (3,139)
- Pilots (21)